SIH Partners’s ResMed RMD Stock Holding History

SIH Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,099	Closed	-$6.29M	–	332
2025 Q4	$6.29M	Buy	26,099 +10,237	+65%	+$2.62M	0.12%	66
2025 Q3	$4.34M	Buy	15,862 +11,175	+238%	+$3.05M	0.12%	66
2025 Q2	$1.21M	Buy	4,687 +3,145	+204%	+$750K	0.05%	90
2025 Q1	$345K	Buy	+1,542	New	+$360K	0.01%	184

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SIH Partners's RMD Position: Q1 2026 in Review

SIH Partners sold out of ResMed (RMD) in Q1 2026, closing a stake of 26,099 shares — an estimated $6.29M sold.

SIH Partners first reported a position in RMD in Q1 2025 and held it in 4 quarters. The position peaked at $6.29M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

SIH Partners reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
SIH Partners sold 26,099 ResMed shares in Q1 2026, an estimated $6.29M.
SIH Partners first reported a position in ResMed in Q1 2025 and held it in 4 quarters.
SIH Partners's ResMed position peaked at $6.29M in Q4 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SIH Partners's 13F filing for Q1 2026, filed 15 May 2026.